Editorial Genetic control of disease in an experimental model for Sjögren's syndromeDepartment of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, Copenhagen University, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark
Arthritis Research & Therapy 2009, 11:102doi:10.1186/ar2583
See related research by Nguyen et al., http://arthritis-research.com/content/10/6/R137 AbstractSjögren's syndrome is an autoimmune disease with a complex etiology depending on hereditary and environmental factors. The disease is characterized by lymphocytic infiltration and inflammation in the salivary and lacrimal glands, leading to oral and ocular dryness. To understand the genetic susceptibility in Sjögren's syndrome, studies of disease phenotypes have been performed in the non-obese diabetic (NOD) mouse. By the identification of genetic regions controlling development of autoimmune exocrinopathy in the NOD mouse and by reducing one of these regions considerably, Nguyen et al. in a recent issue of Arthritis Research and Therapy propose candidate genes for development of Sjögren's syndrome. |




on Google Scholar







author email
corresponding author email